Precision Medicine: Personalizing Healthcare by Bridging Aging, Genetics, and Global Diversity

Precision medicine transforms healthcare by tailoring prevention, diagnosis, and treatment strategies to individual characteristics such as genetics, molecular profiles, environmental factors, and lifestyle. This approach has shown promise in improving treatment efficacy, minimizing adverse effects, and enhancing disease prevention across various conditions, including age-related illnesses, cancer, type 2 diabetes, cardiovascular disease, and rare genetic disorders. However, major challenges remain that limit the potential of precision medicine. A key limitation is the underrepresentation of diverse populations in genetic research, leading to disparities in treatment outcomes and the potential misinterpretation of genetic risks. Current clinical reference intervals often fail to reflect the biological changes associated with aging, increasing the risk of misdiagnosis or inappropriate treatment in older adults. Our model calls for a broader, more inclusive framework, one that incorporates not only individual variability but also population-level factors such as aging and genetic diversity. Emerging technologies in artificial intelligence (AI), digital health, and multi-omics can help support this expanded approach. Precision medicine must include underrepresented populations in research, develop age-specific clinical guidelines, and address socioeconomic barriers. Here, we provide a brief introduction to our model. By integrating aging and genetics, precision medicine can evolve into a truly global approach-one that promotes health equity, respects biological diversity, and improves outcomes for all populations.